Related references
Note: Only part of the references are listed.Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sjogren syndrome (pSS)
Lucie Demaria et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Rheumatoid Factor Reactivity of Expanded CD21-/low B Cells in Patients With Sjogren's Syndrome: Comment on the Article by Glauzy et al
Richard J. Bende et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Usefulness of 18F-Labeled Fluorodeoxyglucose-Positron Emission Tomography for the Diagnosis of Lymphoma in Primary Sjogren's Syndrome
Jeremy Keraen et al.
ARTHRITIS & RHEUMATOLOGY (2019)
B cells in the pathogenesis of primary Sjogren syndrome
Gaetane Nocturne et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Accumulation of Antigen-Driven Lymphoproliferations in Complement Receptor 2/CD21-/low B Cells From Patients With Sjogren's Syndrome
Salome Glauzy et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Ectopic Germinal Center-Like Structures in Minor Salivary Gland Biopsy Tissue Predict Lymphoma Occurrence in Patients With Primary Sjogren's Syndrome
Damien Sene et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren's syndrome
Benjamin A. Fisher et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study
C. Baldini et al.
JOURNAL OF INTERNAL MEDICINE (2017)
Ectopic lymphoid neogenesis in rheumatic autoimmune diseases
Michele Bombardieri et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Overexpression of the Cytokine BAFF and Autoimmunity Risk
M. Steri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Predictable biomarkers of developing lymphoma in patients with Sjogren syndrome: a nationwide population-based cohort study
Yu-Hsiang Chiu et al.
ONCOTARGET (2017)
MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome
Sofia Fragkioudaki et al.
SCIENTIFIC REPORTS (2017)
Germinal centres in diagnostic labial gland biopsies of patients with primary Sjogren's syndrome are not predictive for parotid MALT lymphoma development
Erlin A. Haacke et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Germline variation of TNFAIP3 in primary Sjogren's syndrome-associated lymphoma
Gaetane Nocturne et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients
Akiko Miyagi Maeshima et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use
Sofia Fragkioudaki et al.
MEDICINE (2016)
Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjogren's Syndrome
S. J. Johnsen et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2016)
Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjogren's Syndrome
G. Nocturne et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Predicting the Outcome of Sjogren's Syndrome-Associated Non-Hodgkin's Lymphoma Patients
Aristea Papageorgiou et al.
PLOS ONE (2015)
A BAFF Receptor His159Tyr Mutation in Sjogren's Syndrome-Related Lymphoproliferation
Aristea Papageorgiou et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Stereotypic Rheumatoid Factors That Are Frequently Expressed in Mucosa-Associated Lymphoid Tissue-Type Lymphomas Are Rare in the Labial Salivary Glands of Patients With Sjogren's Syndrome
Richard J. Bende et al.
ARTHRITIS & RHEUMATOLOGY (2015)
CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjogren's Syndrome
G. Nocturne et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Sjogren Syndrome-associated lymphomas: an update on pathogenesis and management
Gaetane Nocturne et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Identification of lymphoma predictors in patients with primary Sjogren's syndrome: a systematic literature review and meta-analysis
Maria B. Nishishinya et al.
RHEUMATOLOGY INTERNATIONAL (2015)
Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis
Yan Liang et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The prognostic value of routinely performed minor salivary gland assessments in primary Sjogren's syndrome
Anna P. Risselada et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma
Shu Yang et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Advances in the understanding and treatment of systemic complications in Sjogren's syndrome
Pilar Brito-Zeron et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjogren Syndrome The JOQUER Randomized Clinical Trial
Jacques-Eric Gottenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Biomarkers of lymphoma in Sjogren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: Results of a multicenter study
Luca Quartuccio et al.
JOURNAL OF AUTOIMMUNITY (2014)
B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome
Adrianos Nezos et al.
JOURNAL OF AUTOIMMUNITY (2014)
Evaluation of Germinal Center-like Structures and B Cell Clonality in Patients with Primary Sjogren Syndrome with and without Lymphoma
Svein Joar Johnsen et al.
JOURNAL OF RHEUMATOLOGY (2014)
Primary Sjogren's Syndrome: Diagnostic and Prognostic Value of Salivary Gland Ultrasonography Using a Simplified Scoring System
Elke Theander et al.
ARTHRITIS CARE & RESEARCH (2014)
First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial
Antonio Salar et al.
LANCET HAEMATOLOGY (2014)
Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome
Gaetane Nocturne et al.
BLOOD (2013)
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
Mathias J. Rummel et al.
LANCET (2013)
Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjogren's Syndrome. Data at Enrollment in the Prospective ASSESS Cohort
Jacques-Eric Gottenberg et al.
PLOS ONE (2013)
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands
Luca Quartuccio et al.
RHEUMATOLOGY (2013)
Risk of Non-Hodgkin's Lymphoma in Primary Sjogren's Syndrome: A Population-Based Study
Svein J. Johnsen et al.
ARTHRITIS CARE & RESEARCH (2013)
Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan
Meng-Yu Weng et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma
Haihan Song et al.
MOLECULAR BIOLOGY REPORTS (2012)
Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome
Elke Theander et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases
S. L. Musone et al.
GENES AND IMMUNITY (2011)
A failure of TNFAIP3 negative regulation maintains sustained NF-κB activation in Sjogren's syndrome
Margherita Sisto et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2011)
Risk, Predictors, and Clinical Characteristics of Lymphoma Development in Primary Sjogren's Syndrome
Roser Solans-Laque et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
The Fms-like Tyrosine Kinase 3 Ligand, a Mediator of B Cell Survival, Is Also a Marker of Lymphoma in Primary Sjogren's Syndrome
Gabriel J. Tobon et al.
ARTHRITIS AND RHEUMATISM (2010)
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes:: a pooled analysis within the InterLymph consortium
Karin Ekstrom Smedby et al.
BLOOD (2008)
Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome
Michele Bombardieri et al.
JOURNAL OF IMMUNOLOGY (2007)
MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation
Alexander J. A. Deutsch et al.
BLOOD (2007)
Development of autoimmunity in IL-14α-transgenic mice
Long Shen et al.
JOURNAL OF IMMUNOLOGY (2006)
Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors
E. Theander et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
E Baecklund et al.
ARTHRITIS AND RHEUMATISM (2006)
No evidence for an association between the-871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjogren's syndrome
JE Gottenberg et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity
RJ Bende et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites
B Streubel et al.
LEUKEMIA (2004)
Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome
JPA Ioannidis et al.
ARTHRITIS AND RHEUMATISM (2002)
The place of magnetic resonance and ultrasonographic examinations of the parotid gland in the diagnosis and follow-up of primary Sjogren's syndrome
E Makula et al.
RHEUMATOLOGY (2000)
Share Paper
